Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Humabs LlcfiledCriticalHumabs Llc
Priority to CR20110090ApriorityCriticalpatent/CR20110090A/es
Publication of CR20110090ApublicationCriticalpatent/CR20110090A/es
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Abstract
La invención describe anticuerpos de neutralización que son específicos para citomegalovirus humano (hCMV), específicamente los anticuerpos de la invención son específicos para una combinación de proteínas de hCMV UL128, UL130 y UL131A.
CR20110090A2011-02-162011-02-16Citomegalovirus humano que neutraliza anticuerpos y su uso
CR20110090A
(es)